Journal of Alzheimer's Disease

Journal of Alzheimer's Disease An international multidisciplinary journal The journal publishes research reports, reviews, short communications, book reviews, and letters-to-the-editor.

JAD is an international multidisciplinary journal to facilitate progress in understanding the etiology, pathogenesis, epidemiology, genetics, behavior, treatment and psychology of Alzheimer’s disease. The journal is dedicated to providing an open forum for original research that will expedite our fundamental understanding of Alzheimer’s disease. Editor-in-Chief
George Perry, PhD
University of Texas at San Antonio
USA
Tel: +1.210.458.8660
Fax:+1.210.458.5658
Email: george.perry@utsa.edu
ORCID iD: 0000-0002-6547-0172

To view the full list of the Editorial Board, please visit: http://j-alz.com/board. JAD is a member of the Neuroscience Peer Review Consortium (http://nprc.incf.org). The Consortium is an alliance of neuroscience journals that have agreed to accept manuscript reviews from each other. Abstracting/Indexing

Biological Abstracts
BIOSIS Previews
CAB Abstracts
CAB Health
Chemical Abstracts Service (CAS)
CSA Biological Sciences
CSA Illumina
CSA Illustrata Natural Sciences
CSA Neurosciences Abstracts
e-psyche database
EBSCO database
Embase
EMCare
Index Copernicus
Index Medicus
Journal Citation Reports/Science Edition
MEDLINE
Neuroscience Citation Index
Prous Science Integrity
PsycInfo
PubMed
PubsHub
Science Citation Index Expanded (SciSearch)
Scopus

Audience

JAD's targeted audience is comprised of basic science researchers and clinicians in the areas of Alzheimer's disease and related disorders.

With Ganadería Zacatepec – I just got recognized as one of their top fans! 🎉
15/01/2026

With Ganadería Zacatepec – I just got recognized as one of their top fans! 🎉

14/01/2026

Acadia outlines its 2026 strategy to build a global neuroscience and rare disease biotech through precision medicine, data innovation, and patient-driven growth.

14/01/2026

DIAGNOSIS VIDEO: As we age, we change. Learn to spot changes that are Alzheimer's warning signs, versus changes that just mean a person is aging nicely.

14/01/2026

Posterior Cortical Atrophy, or PCA, is a specific form of Alzheimer’s that affects the back of the brain. Author Terry Pratchett had it.

14/01/2026

VIDEO+ARTICLE: Multiple studies affirm bingo exercises attention, memory, and social connection all at once. Learn about its small but meaningful role in dementia care—when used the right way.

14/01/2026

Ever walk into a room with some purpose in mind, only to forget what it was? It turns out, doors themselves are to blame for these lapses.

14/01/2026

Why does Leqembi cause fewer ARIA side effects in Asia? Genetics, not geography, may explain the difference—and what it means for families.

13/01/2026

News and commentary from the world of neurology and neuroscience

13/01/2026

Menopause hormone therapy neither increases nor decreases the risk for dementia or mild cognitive impairment in postmenopausal women, a meta-analysis finds.

13/01/2026

In Alzheimer’s, an Immune Boost Quiets Plasma Markers Quick Links Article Comments References Further Reading Tools Add to my Library Follow Comments Share How would you like to share? Facebook X LinkedIn Back to the Top 09 Jan 2026 Inflammation is known to contribute to Alzheimer’s disease prog...

Adres

Nieuwe Hemweg 6B
Amsterdam
1013BG

Meldingen

Wees de eerste die het weet en laat ons u een e-mail sturen wanneer Journal of Alzheimer's Disease nieuws en promoties plaatst. Uw e-mailadres wordt niet voor andere doeleinden gebruikt en u kunt zich op elk gewenst moment afmelden.

Contact De Praktijk

Stuur een bericht naar Journal of Alzheimer's Disease:

Delen

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram